CNS Embryonal Tumor

Oncology·MeSH: Pinealoma

12 drugs in development·1 company·1 clinical trial

Drug Pipeline by Phase

Phase 2(5)

Drug	Company
Celecoxib	AIM ImmunoTech Inc. (AIM)
Cytarabine IT	AIM ImmunoTech Inc. (AIM)
Etoposide	AIM ImmunoTech Inc. (AIM)
etoposide phosphate	AIM ImmunoTech Inc. (AIM)
Temozolomide	AIM ImmunoTech Inc. (AIM)

Early Phase 1(7)

Drug	Company
Filgrastim	AIM ImmunoTech Inc. (AIM)
hydrocortisone	AIM ImmunoTech Inc. (AIM)
ISOtretinoin	AIM ImmunoTech Inc. (AIM)
Mesna	AIM ImmunoTech Inc. (AIM)
Thiotepa	AIM ImmunoTech Inc. (AIM)
Topotecan IT	AIM ImmunoTech Inc. (AIM)
Vincristine	AIM ImmunoTech Inc. (AIM)

Compare drugs

Celecoxib vs Cytarabine IT Celecoxib vs Etoposide Celecoxib vs etoposide phosphate

Frequently asked questions

How many drugs are in development for CNS Embryonal Tumor?

BioSniper tracks 12 drugs in development for CNS Embryonal Tumor across 1 company.

How many clinical trials target CNS Embryonal Tumor?

There are 1 clinical trial targeting CNS Embryonal Tumor tracked by BioSniper.

Deep-dive into CNS Embryonal Tumor

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis

CNS Embryonal Tumor — Drugs in Development & Clinical Trials | BioSniper